The natural product engelhardione is an underexplored chemotype for developing novel treatments for bacterial infections; we therefore explored this natural product scaffold for chemical diversification and structure-activity relationship studies. Macrocyclic engelhardione and structural regioisomers were synthesized using a series of aldol condensations and selective hydrogenations to generate the 1,7-diarylheptan-3-one derivatives, followed by microwave-assisted intramolecular Ullmann coupling to afford a series of macrocyclic diaryl ether analogs. An extended macrocyclic chemical library was then produced by oxime formation, reductive amination and O-alkylation. Antibacterial evaluation revealed that the reductive amination derivatives 7b and 7d showed moderate activities (minimum inhibitory concentrations: 12.5-25 mg ml À1 ) against Mycobacterium tuberculosis and Gram-positive pathogens, as well as anti-Gram-negative activity against an efflux impaired Escherichia coli strain. These results provide validated leads for further optimization and development.
INTRODUCTION
Because of the emergence and spread of drug-resistant Mycobacterium tuberculosis and other pathogenic bacterial infections, there is an urgent need to discover new chemotype antitubercular and antibacterial agents with novel mechanisms of action. 1, 2 Only five novel chemical classes of antibiotics, exemplified by linezolid, daptomycin, retapamulin, fidaxomicin and bedaquiline, have been introduced into the clinic since the early 1960s. 3 Among antibacterial discovery strategies, whole-cell-based phenotypic screens of smallmolecule and/or natural product-like libraries, followed by target deconvolution and identification, remain an attractive and efficient approach. 4 Natural products represent one of the most valuable sources for novel bioactive molecules and chemical diversity in drug discovery. 5 Indeed, most antibiotics in clinical use are natural products, semisynthetic and/or natural product-inspired derivatives. 6 Notably, most clinically used natural product antibiotics are derived from microorganisms such as bacteria and fungi, and no plant-derived antibacterial agents have been used clinically. 3 Macrocyclic diarylheptanoids belong to a chemical class of bioactive naturally occurring phytochemicals, which display a characteristic diphenyl ether motif linked by a seven carbon bridge. 7 As acerogenin A, the first member in the cyclic diarylheptanoid class, was isolated and reported by the Nagai's group in 1976, 8 diverse diarylheptanoids [9] [10] [11] [12] [13] [14] [15] [16] have been isolated and found to mediate a variety of biological activities ( Figure 1 ). One such example, engelhardione, was recently isolated from the roots of Engelhardia roxburghiana and reported to show potent antituberculosis activity with a minimum inhibitory concentration (MIC) of 0.2 mg ml À1 . 17 As our continued effort to develop natural products-derived novel antibacterial agents, we have been interested in the chemical modification of emerging natural product scaffolds. Inspired by the reported potent antitubercular activity of engelhardione and the limited attention given to exploring this macrocyclic molecule, we directed medicinal chemistry efforts toward this promising natural product scaffold. Consequently, we recently reported the first total synthesis of the published structure (1a) of engelhardione and this effort led to its structural revision to that of pterocarine (1b; Figure 1 ). 18 The structural revision was also subsequently confirmed by the Natarajan's group 9 and the Chen's group. 19 To further improve the efficiency of macrocyclization, we developed an efficient and modular microwave-assisted macrocyclization via intramolecular Ullmann coupling and investigated the scope and generality of a panel of substrates with different linkers, ring sizes and substitution patterns. 20 To extend the medicinal chemistry effort of this work and to investigate if this cyclic diarylheptanoid architecture possesses any tractable antibacterial activity, herein we report the synthesis, antibacterial evaluation and preliminary structure-activity relationships of this class of macrocyclic diarylheptanoids against M. tuberculosis and a broad panel of Gram-positive and Gram-negative pathogens. This work constitutes the first systematic report describing the antitubercular and antibacterial evaluation of synthetic engelhardione, pterocarine and related structural analogs. Our preliminary mechanistic study identified that lead compounds inhibited several key macromolecular processes (DNA, RNA and protein).
RESULTS AND DISCUSSION
Chemistry As illustrated in Scheme 1, starting from 1,7-diarylhepten-3-one 2a-c, 18 the proposed structure (1a) of engelhardione, pterocarine (1b) and their regioisomer (1c) were synthesized by a series of cross aldol condensations and selective hydrogenations, affording linear 1,7-diaryl-3-ketones as a key intermediate (3a-c), followed by intramolecular Ullmann reactions to give the macrocyclic architectures 4a-c and final O-demethylation (Scheme 1).
To evaluate the influence of the carbonyl group on the antibacterial activity, compounds 5-7 were then designed and synthesized. First, the carbonyl group of engelhardione dimethyl ether (4a) was reduced to the racemic secondary alcohol (5) by reaction with NaBH 4 in a quantitative yield (Scheme 2). Second, reaction of 4a with different substituted hydroxylamine hydrochloride in the presence of pyridine in ethanol at room temperature afforded the oxime derivatives 6a-c. 21 In the cases of 6b and 6c, based on their 1 H NMR spectra, a mixture of E and Z oxime isomers in an approximate ratio of 1:1 and 1:2 was obtained, respectively. Initial attempts to prepare Schiff base imines from the reaction of 4a with amines were unsuccessful because of the facile decomposition of imine products during the work-up and purification. The one-pot syntheses of the secondary amine analogs 7a-e were achieved by reacting 4a with an array of different substituted amines, followed by NaBH 4 -mediated reduction in a sealed tube under solvent-free conditions. In all cases, the reactions proceeded smoothly to give products 7a-e in fair to good yields (47-78%).
Next, synthesis of different substituted engelhardione O-alkyl analogs 13a-f was carried out by employing an orthogonal protecting strategy and adapting the similar synthetic scheme as used for 4a (Scheme 3). The conjugated diarylhepten-3-one 2d was obtained by Claisen-Schmidt condensation of 8 with methoxymethyl ether (MOM)-protected benzaldehyde 10, 22 followed by chemoselective hydrogenation to give the 1,7-diphenylheptan-3-one 3d. 23 Intramolecular macrocyclic Ullmann reaction was then performed under microwave irradiation to give the MOM-protected macrocycle 11 in good yield (85%). The MOM-deprotected macrocyclic phenol 
12 was then prepared by deprotection of 11 with concentrated HCl in methanol at room temperature in high yield. Finally, in the presence of appropriate bases, 12 was subjected to the reactions with different alkyl bromides to afford a series of O-alkylated macrocycles 13a-f in 47-94% yields.
Biology
To evaluate the potential for antituberculosis and broad-spectrum antibacterial activities, all the linear 1,7-diarylheptanoid intermediates and macrocyclic engelhardione analogs were tested against M. tuberculosis and a panel of Gram-positive and Gram-negative pathogens including Enterococcus faecalis, Staphylococcus aureus (MSSA), Staphylococcus aureus (MRSA), Escherichia coli (K12), Escherichia coli (DTolC), Klebsiella pneumonia and Pseudomonas aeruginosa. The results are shown in Table 1 and preliminary structure-activity relationships are summarized below.
Most linear chain diarylheptanoid compounds 2 and 3 were inactive. The engelhardione analogs 1a-c and their corresponding methyl ether derivatives 4a-c only showed marginal antibacterial activities. Unfortunately, both the originally published structure 17 (1a) of engelhardione and pterocarine (1b) only showed weak antituberculosis activity (200 mg ml À1 ) in our assay. These results are consistent with a recent report by Reddy and co-workers 24 that corniculatolides, close structural lactone analogs of engelhardione/ pterocarine diarylheptanoids, did not inhibit the growth of M. tuberculosis at 100 mg ml À1 .
The oxime derivative 6a showed slight activity against S. aureus (ATCC 29213) (MSSA) (MIC ¼ 100 mg ml À1 ). Improved activities were obtained for the reductive amination products 7b-e; in particular, compounds 7b and 7d containing secondary amine functionality exhibited antibacterial activities against M. tuberculosis, E. faecalis, S. aureus MSSA and MRSA with MIC values of 12.5-25 mg ml À1 . Interestingly, compounds 7b-e also showed moderate activity against an E. coli strain that is deficient in TolC, a critical component of the AcrAB-TolC efflux system that pumps antibiotics out of the periplasm. 25 In contrast, compound 7a with an additional morpholine motif in this N-substituted amine series was not active, possibly due to the increased polarity and decreased cellular membrane penetration. It is worthwhile to note that compounds 7b-e were not active toward wild-type E. coli strain. This result suggests that these compounds may be subject to efflux pump-mediated resistance mechanism and explains their lack of activity against Gram-negative bacteria.
The O-alkylated cyclic derivative 13e with an isopropyl group showed moderate antituberculosis activity (MIC ¼ 25 mg ml À1 ), but all the other compounds in this series were inactive. Relative % inhibition
Figure 2 Inhibition of macromolecular synthesis by 7b-d. Indicated are the standard error of means from three or more biologically independent experiments. SM, streptomycin (MIC, 1.6 mg ml À1 ); CPFX, ciprofloxacin (MIC, 0.40 mg ml À1 ); RFP, rifampicin (MIC, 12.5 mg ml À1 ).
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To explore the basis for the antibacterial activities of selected compounds, their effects on the biosynthesis of key macromolecules were examined against the E. coli TolC deletion mutant. These effects were examined at low and elevated concentrations (that is, 1 and 8 Â the MIC) to determine concentration-dependent effects that may point to a specific process as the main antibacterial target. Interestingly, the biosynthesis of DNA, RNA and protein were all highly inhibited by the compounds 7b-d at 1 and 8 Â their MICs (Figure 2) , which may be indicative of a nonspecific mode of action, possibly at the cell envelope. This is similar to the effects observed in cells treated with the macrocycles daptomycin and telavancin that target the bacterial envelope and disrupt multiple processes in cells. 26, 27 In summary, a small focused library of diarylheptanoid engelhardione and derivatives bearing the oxime, and N-and O-alkylated functionalities were designed and synthesized. Antituberculosis and antibacterial evaluation revealed that the N-substituted secondary amine derivatives demonstrated moderate antitubercular and antibacterial activities. In particular, compound 7b with a phenethylamine substituent and compound 7d with a n-hexylamino moiety demonstrated the most potent antibacterial activity against M. tuberculosis, E. faecalis and S. aureus with MICs ranging from 12.5 to 25 mg ml À1 . Based on the existing structure-activity relationships, further synthesis and optimization are ongoing in an effort to obtain compounds with improved antibacterial potency and therapeutic potential.
EXPERIMENTAL PROCEDURE Chemistry
All reagents and solvents obtained from commercial sources were used without further purification. Reactions were monitored by high-performance liquid chromatography (HPLC) with a Shimadzu LC-20A series HPLC system (Shimadzu Scientific Instruments, Carlsbad, CA, USA). Hydrogenation reactions were carried out using domnick hunter NITROX UHP-60H hydrogen generator (Parker Hannifin Corp, Cleveland, OH, USA). Reactions in sealed tube were carried out using Q-Tube pressure tube reactors from Q Lab tech (Waterford, CT, USA). Microwave-assisted synthesis was performed by Biotage Initiator 8 Exp Microwave System (Biotage, LLC, Charlotte, NC, USA). Flash column chromatography was performed using a Biotage Isolera One system and a Biotage SNAP cartridge (Biotage). 1 H NMR and 13 C NMR and 2D HSQC, COSY, HMBC spectra were recorded employing a Bruker AM-400 spectrometer (Bruker BioSpin Corporation, Fremont, CA, USA). Chemical shifts were expressed in p.p.m. and J values were in Hz. Mass spectra were recorded on a Varian 500-MS IT mass spectrometer using ESI (Agilent Technologies, Santa Clara, CA, USA). The purity of compounds was determined by analytical HPLC using a Gemini, 3 mm, C18, 110 Å column (50 mm Â 4.6 mm; Phenomenex, Torrance, CA, USA) and a flow rate of 1.0 ml min À1 . Gradient conditions used were: solvent A (0.1% trifluoroacetic acid in water) and solvent B (acetonitrile): 0-2.00 min, 100% A, 2.00-7.00 min, 0-100% B (linear gradient), 7.00-8.00 min, 100% B, and UV detection at 254 and 220 nm.
Syntheses of engelhardione (1a), pterocarine (1b), regioisomer (1c) and their corresponding synthetic precursors (2-4) were described previously. 18, 20 Syntheses of 2d, 3d, 5 and 10-12 were described in the Supplementary Information.
Compound 6a: To a suspension of hydroxylamine hydrochloride (13.6 mg, 0.196 mmol) in ethanol (2 ml), 15.8 ml (0.196 mmol) of pyridine was added dropwise, followed by the addition of engelhardione dimethyl ether 4a (16.5 mg, 0.049 mmol). The reaction was stirred at room temperature for 7 h. The ethanol was evaporated to give a white powder, which was washed with water and ethyl acetate to give the product as a white powder (91%). 1 Compound 6b: 6b was prepared as described above for compound 6a from 4a (20 mg, 0.059 mmol) with methoxylamine hydrochloride (19.7 mg, 0.24 mmol). After ethanol was removed, the solid was dissolved in dichloromethane and washed with water. The organic layer was dried over anhydrous Na 2 SO 4 and then filtered. Solvent was removed by evaporation to give the crude product, which was further purified by flash column chromatography on silica gel (hexanes/ethyl acetate, 88:12) to give 18.2 mg white powder as a mixture of Z-and E-oxime isomers (approximately 1:1 ratio based on 1 H NMR spectrum) (84%). 1 Compound 6c: 6c was prepared as described above for compound 6b from 4a (18 mg, 0.053 mmol) with benzyloxylamine hydrochloride (33.9 mg, 0.212 mmol). The reaction mixture was purified by flash column chromatography on silica gel (hexanes/ethyl acetate, 90:10) to give 21.4 mg white powder as a mixture of Z-and E-oxime isomers (approximately 1:2 ratio based on 1 H NMR spectrum) (91%). 1 Compound 7a: A mixture of engelhardione dimethyl ether 4a (15.0 mg, 0.044 mmol) and 2-morpholinoethanamine (60 ml, 0.46 mmol) in a sealed tube was heated at 70 1C for overnight. NaBH 4 (16.7 mg, 0.44 mmol) was then added, and the mixture was stirred at 70 1C for 10 min. The reaction mixture was cooled to room temperature, and water (2 ml) was added carefully, and the resulting mixture was extracted with ethyl acetate (2 Â 10 ml). The organic layers were combined, washed with brine and dried over anhydrous Na 2 SO 4 . The solvent was removed by evaporation to give the crude product, which was further purified by flash column chromatography on silica gel (DCM/MeOH, 91:9) to give 12 mg of white powder (60%). 1 Compound 7b: 7b was prepared as described above for compound 7a from 4a (18.2 mg, 0.054 mmol) with 2-phenylethanamine to give 12 mg of product (50%). 1 Biological studies MIC determination. MIC values were determined against M. tuberculosis (H37Rv) and other bacteria using the standard microbroth dilution method exactly as described previously, 28 which is based on the methods by the Clinical and Laboratory Standards Institute. 29 The maximum test concentration used against M. tuberculosis and other pathogens was 200 mg ml À1 .
Macromolecular synthesis. The effects of selected active compounds 7b-d (at 1 and 8 Â MIC) on DNA, RNA and protein, respectively, were determined on mid-logarithmic E. coli DTolC (OD 600 ¼ 0.4), by measuring the incorporation of the radiolabeled precursors (methyl-3 H)thymidine, (5,6-3 H)uridine and (4,5-3 H)leucine into macromolecular fractions as described previously. 30, 31 Briefly, cells were mixed with tested compound for 5 min before the addition of precursors at 1 mCi ml À1 . After an additional 20 min, cells were lysed with cold 10% TCA and precipitated macromolecules collected on GF/C filters. After washing with 95% ethanol, GF/C filters were analyzed by liquid scintillation counting. The relative % activity in cells exposed to compounds was determined. Ciprofloxacin (DNA), rifampicin (RNA) and streptomycin (protein) were used as positive controls.
